Joanne Anstee

Pathway 0+3.5

Cohort 2018

0+3.5 Student

I graduated from the University of Cambridge in 2018 with a degree in Biological Natural Sciences, majoring in Cancer and Genetic Diseases and Immunology. During my time at university I undertook research placements at the University of Cambridge, University College London and King’s College London. These research placements alongside the theoretical elements of my degree fuelled my interest to study a PhD focusing on cancer immunotherapy. 

I chose the MRC DTP programme because of the wide range of projects available, the extensive developmental workshops on offer and the great networking opportunities within the cohort.  

 PhD project 

Investigation into novel immunotherapeutics which target the development of tumour associated macrophages in cancer 


Opzoomer, J. W., Anstee, J. E., Dean, I., Hill, E. J., Bouybayoune, I., Caron, J., Muliaditan, T., Gordon, P., Nuamah, R., Pinder, S. E., Ng, T., Dazzi, F., Kordasti, S., Withers, D. R., Lawrence, T., & Arnold, J. N. (2020). Lyve-1 expressing perivascular macrophages orchestrate pericyte expansion to sustain angiogenesis in cancer. bioRxiv, 2020.2010.2030.361907. 

 Opzoomer, J. W., Sosnowska, D., Anstee, J. E., Spicer, J. F., & Arnold, J. N. (2019). Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer. Frontiers in Immunology, 10, (1654). 

Casey, R. T., Hoopen, R. T., Ochoa, E., Challis, B. G., Whitworth, J., Smith, P. S., Martin, J. E., Clark, G. R., Rodger, F., Maranian, M., Allinson, K., Madhu, B., Roberts, T., Campos, L., Anstee, J., Park, S., Marker, A., Watts, C., Bulusu, V. R., Giger, O. T., & Maher, E. R. (2019). SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice. Scientific Reports, 9(1), 10244.